Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.
Saved in:
| Title: | Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States. |
|---|---|
| Authors: | Baljoon A; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Diaby V; Independent Researcher, Gainesville, FL, 32606, USA., Suther S; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Dutton M; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Ali A; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Eljilany I; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, 10920 McKinley Dr., Tampa, FL, 33612, USA. islam.eljilany@hotmail.com. |
| Source: | PharmacoEconomics - open [Pharmacoecon Open] 2026 May; Vol. 10 (3), pp. 457-469. Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101700780 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-4254 (Electronic) Linking ISSN: 25094262 NLM ISO Abbreviation: Pharmacoecon Open Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2509-4254 |
|---|---|
| DOI: | 10.1007/s41669-026-00643-0 |
